Projected Income Statement: Ipsen

Forecast Balance Sheet: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 138 -385 -52.9 -135 -545 -1,362 -2,372 -3,152
Change - -378.99% 86.26% -155.2% -303.7% -150.14% -74.16% -32.88%
Announcement Date 2/11/22 2/9/23 2/8/24 2/13/25 2/12/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 96 96.6 116.2 173 105.3 125.6 132.6 141.5
Change - 0.62% 20.29% 48.88% -39.13% 19.3% 5.55% 6.72%
Free Cash Flow (FCF) 1 813.2 874.8 710.9 774.4 1,033 1,083 1,145 1,166
Change - 7.58% -18.74% 8.93% 33.41% 4.79% 5.74% 1.89%
Announcement Date 2/11/22 2/9/23 2/8/24 2/13/25 2/12/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 40.64% 44.57% 28.18% 35.28% 35.21% 38.94% 37.71% 35.74%
EBIT Margin (%) 35.25% 36.87% 32.01% 32.62% 32.94% 33.3% 32.6% 31.35%
EBT Margin (%) 28.39% 23.34% 24.35% 12.69% 14.73% 28.15% 27.14% 25.42%
Net margin (%) 22.54% 21.4% 20.69% 10.21% 11.31% 21.7% 20.98% 20.19%
FCF margin (%) 28.35% 28.92% 22.73% 22.77% 26.29% 25.45% 25.61% 25.05%
FCF / Net Income (%) 125.77% 135.1% 109.84% 222.98% 232.42% 117.28% 122.07% 124.1%

Profitability

        
ROA 13.88% 16.46% 12.83% 13.44% 15.09% 12.8% 11.58% 10.35%
ROE 26.49% 28.73% 21.36% 21.43% 23.69% 21.61% 18.76% 19.01%

Financial Health

        
Leverage (Debt/EBITDA) 0.12x - - - - - - -
Debt / Free cash flow 0.17x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.35% 3.19% 3.72% 5.09% 2.68% 2.95% 2.97% 3.04%
CAPEX / EBITDA (%) 8.23% 7.16% 13.18% 14.42% 7.61% 7.58% 7.87% 8.5%
CAPEX / FCF (%) 11.81% 11.04% 16.35% 22.34% 10.19% 11.6% 11.58% 12.13%

Items per share

        
Cash flow per share 1 10.91 11.72 10.39 10.94 13.65 15.63 16.44 13.62
Change - 7.38% -11.36% 5.33% 24.81% 14.45% 5.23% -17.19%
Dividend per Share 1 1.2 1.2 1.2 1.4 1.4 1.431 1.484 1.582
Change - 0% 0% 16.67% 0% 2.22% 3.68% 6.61%
Book Value Per Share 1 33.33 - 45.64 49.89 51.73 60.91 73.84 85.36
Change - - - 9.32% 3.69% 17.74% 21.23% 15.61%
EPS 1 7.76 7.81 7.73 4.15 5.32 10.81 11.07 11.15
Change - 0.64% -1.02% -46.31% 28.19% 103.18% 2.46% 0.63%
Nbr of stocks (in thousands) 82,243 82,380 82,599 82,700 82,100 82,100 82,100 82,100
Announcement Date 2/11/22 2/9/23 2/8/24 2/13/25 2/12/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 14.5x 14.2x
PBR 2.58x 2.13x
EV / Sales 2.71x 2.36x
Yield 0.91% 0.94%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
157.20EUR
Average target price
160.00EUR
Spread / Average Target
+1.78%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!